Reports for FRESENIUS KABI CANADA LTD
Company Name FRESENIUS KABI CANADA LTD |
||
|---|---|---|
Totals |
||
Shortage reports |
341 |
|
| Actual shortage: | 5 (1%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 331 (97%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
51 (15%) |
|
Overdue reports |
3 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VORICONAZOLE FOR INJECTION | 200MG | POWDER FOR SOLUTION | Resolved | 2022-02-08 | 2022-12-04 | 154479 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2